MMedication Read More Growing use of GLP-1 drugs, not price, drives spending in Delaware16 September 2025 Costs remain flat, but manufacturer rebates grow Delaware officials looked at prescribing data and cost information for fully…
MMedication Read More How the ‘Ozempic effect’ is reshaping the global economy13 September 2025 Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
MMedication Read More IMA warns of misuse, mis-prescription of new weight-loss drugs, such as Wegovy and Mounjaro23 August 2025 The Indian Medical Association (IMA) has sounded a warning bell on the potential misuse and mis-prescription of weight-loss…
MMedication Read More Prevent Muscle Loss on GLP-1 Weight Loss Medications22 August 2025 With more than 15 million Americans taking GLP-1 medications like Ozempic, Wegovy and Mounjaro, experts say patients could…
MMedication Read More Will you take Wegovy to lose weight?1 August 2025 Wegovy is now available in Singapore more than two years after it was approved by the Health Sciences…
MMedication Read More The weight loss drug market has gotten messy. What to know.25 June 2025 Earlier this week, Novo Nordisk tore up a partnership with the telehealth storefront Hims & Hers Health, which had…
MMedication Read More Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows – National4 June 2025 American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence…
MMedication Read More Food and fitness make or break success on weight loss meds, report finds30 May 2025 Drugs like Wegovy and Zepbound — GLP-1 medications typically used to treat obesity — can lead to impressive…